HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to tame aggressive blood cancers
Disease control TerminatedThis study tested whether combining two drugs, omacetaxine and venetoclax, could help control acute myeloid leukemia or myelodysplastic syndrome that had returned or stopped responding to other treatments in patients with a specific genetic change called RUNX1. The goal was to fi…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for cancer patients with dangerous drug side effect
Disease control TerminatedThis study tested two drug combinations to treat severe lung inflammation (pneumonitis) in cancer patients. The inflammation was a serious side effect of certain cancer immunotherapies that didn't improve with standard steroid treatment. Researchers compared infliximab with intra…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Early COVID-19 treatment trial for vulnerable cancer patients halted
Disease control TerminatedThis early-stage study tested whether two immune-stimulating drugs (rintatolimod and interferon) could help cancer patients fight off COVID-19 infections. The trial aimed to find safe doses and see if the treatment reduced the amount of virus in patients. It was designed for adul…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Two-Pronged attack tested against brain tumors
Disease control TerminatedThis early-phase study tested a combination of two drugs, bintrafusp alfa and pimasertib, for patients with cancer that had spread to the brain (brain metastases). The goal was to find a safe dose and see if the combination could help control the brain tumors and help patients li…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New care strategies aim to help frail patients survive and thrive after risky transplants
Symptom relief TerminatedThis study tested different supportive care approaches to help older or frail patients with blood diseases recover better after a donor stem cell transplant. Researchers compared symptom-focused care, management of other health conditions, a combination of both, and standard care…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:14 UTC